KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Deferred Taxes (2021 - 2023)

Moderna (MRNA) has disclosed Deferred Taxes for 3 consecutive years, with -$106.0 million as the latest value for Q4 2023.

  • For Q4 2023, Deferred Taxes fell 23.26% year-over-year to -$106.0 million; the TTM value through Sep 2024 reached -$106.0 million, down 112.5%, while the annual FY2023 figure was $828.0 million, 248.12% up from the prior year.
  • Deferred Taxes hit -$106.0 million in Q4 2023 for Moderna, down from $1.5 billion in the prior quarter.
  • Across five years, Deferred Taxes topped out at $1.5 billion in Q3 2023 and bottomed at -$310.0 million in Q1 2023.
  • Average Deferred Taxes over 3 years is -$4.1 million, with a median of -$101.5 million recorded in 2022.
  • Year-over-year, Deferred Taxes plummeted 945.45% in 2022 and then surged 1609.28% in 2023.
  • Moderna's Deferred Taxes stood at -$229.0 million in 2021, then soared by 62.45% to -$86.0 million in 2022, then fell by 23.26% to -$106.0 million in 2023.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$106.0 million, $1.5 billion, and -$220.0 million for Q4 2023, Q3 2023, and Q2 2023 respectively.